Boill Healthcare Holdings' high P/S ratio is backed by its robust revenue growth over the past three years, outperforming the industry outlook. Investors anticipate further revenue growth, bolstering the high P/S ratio. The share price will remain strong unless recent medium-term conditions alter.
黄仁勋 : 我给你打电话,你看见了吗?